Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO).
- Citation:
- Immunotherapy vol 13 (9) 727-734
- Year:
- 2021
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Received
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 3258
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, UG1CA233180, UG1CA233253, UG1CA233247, UG1CA233339, UG1CA232760
- Corr. Author:
- Authors:
- Jacob M Sands Sumithra J Mandrekar David Kozono Geoffrey R Oxnard Shauna L Hillman Dennis A Wigle Ramaswamy Govindan Jennifer Carlisle Jhanelle Gray Joseph K Salama Luis Raez Apar Ganti Nathan Foster Shakun Malik Jeffrey Bradley Karen Kelly Suresh S Ramalingam Thomas E Stinchcombe
- Networks:
- CORA, FL023, FL065, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC010, NE003
- Study
- Alliance-A081801
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- NSCLC, adjuvant chemotherapy, lung adenocarcinoma, lung squamous cell carcinoma, pembrolizumab